Luye Pharma Group Ltd. (HKG: 2186)
Hong Kong
· Delayed Price · Currency is HKD 2.120
0.00 (0.00%)
Jan 3, 2025, 11:59 AM HKT
Luye Pharma Group Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 6,314 | 6,143 | 5,982 | 5,200 | 5,540 | 6,358 | Upgrade
|
| Revenue Growth (YoY) | 4.62% | 2.70% | 15.03% | -6.13% | -12.87% | 22.90% | Upgrade
|
| Cost of Revenue | 1,974 | 1,939 | 1,841 | 1,803 | 1,549 | 1,479 | Upgrade
|
| Gross Profit | 4,339 | 4,204 | 4,141 | 3,397 | 3,991 | 4,879 | Upgrade
|
| Selling, General & Admin | 2,428 | 2,700 | 2,403 | 2,276 | 2,185 | 2,564 | Upgrade
|
| Other Operating Expenses | 626.81 | 616.6 | 948.82 | 757.72 | 816.86 | 720.46 | Upgrade
|
| Operating Expenses | 3,054 | 3,317 | 3,351 | 3,033 | 3,002 | 3,285 | Upgrade
|
| Operating Income | 1,285 | 887.44 | 789.14 | 363.4 | 988.38 | 1,595 | Upgrade
|
| Interest Expense | -646.45 | -675.45 | -471.76 | -399.46 | -424 | -295.46 | Upgrade
|
| Interest & Investment Income | 202.38 | 209.97 | 176.1 | 189.69 | 151.05 | 144.8 | Upgrade
|
| Earnings From Equity Investments | 0.91 | 0.79 | 0.83 | 0.7 | 1.73 | 1.21 | Upgrade
|
| Currency Exchange Gain (Loss) | -24.64 | 46.03 | 106.2 | -24.09 | 49.75 | 21.1 | Upgrade
|
| Other Non Operating Income (Expenses) | 207.22 | 241.77 | 109.08 | 129.65 | 202.4 | 148.5 | Upgrade
|
| EBT Excluding Unusual Items | 1,024 | 710.54 | 709.59 | 259.88 | 969.31 | 1,615 | Upgrade
|
| Gain (Loss) on Sale of Investments | -10.94 | 1.94 | 1.55 | -14.81 | -3.46 | 9.4 | Upgrade
|
| Gain (Loss) on Sale of Assets | 1.5 | 1.5 | -0.21 | 11.36 | 0.09 | 9.78 | Upgrade
|
| Legal Settlements | -14.52 | -14.52 | -14.07 | -273.48 | - | - | Upgrade
|
| Other Unusual Items | 0.63 | 0.63 | -27.09 | -57.51 | -23.76 | - | Upgrade
|
| Pretax Income | 1,001 | 700.1 | 669.76 | -74.56 | 942.17 | 1,634 | Upgrade
|
| Income Tax Expense | 169.19 | 161.02 | 86.47 | 70.23 | 238.91 | 279.83 | Upgrade
|
| Earnings From Continuing Operations | 831.9 | 539.08 | 583.3 | -144.78 | 703.27 | 1,354 | Upgrade
|
| Minority Interest in Earnings | -61.44 | -6.47 | 21.51 | 10.39 | 3.32 | 42.08 | Upgrade
|
| Net Income | 770.46 | 532.61 | 604.81 | -134.39 | 706.59 | 1,396 | Upgrade
|
| Net Income to Common | 770.46 | 532.61 | 604.81 | -134.39 | 706.59 | 1,396 | Upgrade
|
| Net Income Growth | 68.30% | -11.94% | - | - | -49.39% | 7.12% | Upgrade
|
| Shares Outstanding (Basic) | 3,762 | 3,728 | 3,481 | 3,445 | 3,187 | 3,203 | Upgrade
|
| Shares Outstanding (Diluted) | 3,762 | 3,728 | 3,481 | 3,445 | 3,194 | 3,221 | Upgrade
|
| Shares Change (YoY) | 4.81% | 7.11% | 1.03% | 7.87% | -0.85% | -0.01% | Upgrade
|
| EPS (Basic) | 0.20 | 0.14 | 0.17 | -0.04 | 0.22 | 0.44 | Upgrade
|
| EPS (Diluted) | 0.20 | 0.14 | 0.17 | -0.04 | 0.22 | 0.43 | Upgrade
|
| EPS Growth | 60.58% | -17.78% | - | - | -48.96% | 7.14% | Upgrade
|
| Free Cash Flow | -121.3 | 962.83 | 998.11 | -373.83 | 340.64 | 423.29 | Upgrade
|
| Free Cash Flow Per Share | -0.03 | 0.26 | 0.29 | -0.11 | 0.11 | 0.13 | Upgrade
|
| Dividend Per Share | - | - | - | - | - | 0.113 | Upgrade
|
| Dividend Growth | - | - | - | - | - | 13.00% | Upgrade
|
| Gross Margin | 68.73% | 68.44% | 69.22% | 65.32% | 72.04% | 76.74% | Upgrade
|
| Operating Margin | 20.35% | 14.45% | 13.19% | 6.99% | 17.84% | 25.08% | Upgrade
|
| Profit Margin | 12.20% | 8.67% | 10.11% | -2.58% | 12.76% | 21.96% | Upgrade
|
| Free Cash Flow Margin | -1.92% | 15.67% | 16.69% | -7.19% | 6.15% | 6.66% | Upgrade
|
| EBITDA | 1,968 | 1,553 | 1,426 | 906.88 | 1,467 | 2,023 | Upgrade
|
| EBITDA Margin | 31.17% | 25.28% | 23.83% | 17.44% | 26.48% | 31.81% | Upgrade
|
| D&A For EBITDA | 683.22 | 665.47 | 636.47 | 543.48 | 478.79 | 428.04 | Upgrade
|
| EBIT | 1,285 | 887.44 | 789.14 | 363.4 | 988.38 | 1,595 | Upgrade
|
| EBIT Margin | 20.35% | 14.45% | 13.19% | 6.99% | 17.84% | 25.08% | Upgrade
|
| Effective Tax Rate | 16.90% | 23.00% | 12.91% | - | 25.36% | 17.13% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.